IPO
-
-
-
-
-
-
-
Decibel Therapeutics Reports First Quarter 2021 Financial Results and Corporate Update
-
-
-
-
-
-
-
Decibel Therapeutics Presents Promising Preclinical Findings on DB-OTO, Gene Therapy Product Candidate Designed to Provide Hearing to Individuals with Otoferlin Mutations
-
-
-
-
-
99,421 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All